Category: Oncology

Lung Cancer (non small cell lung cancer) new treatment approval by FDA for MET exon 14 skip mutation – Capmatinib (Tabrecta, Novartis Pharmaceuticals Corp.)

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capmatinib-metastatic-non-small-cell-lung-cancer